BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 30, 1999
View Archived Issues
Phase I clinical trial of Ushercell completed
Read More
Company Profile: HepaVec
Read More
DWH-146e and rolipram synergistically block inflammation in murine model of peritonitis
Read More
Cortecs changes identity to reflect new strategy
Read More
Neuronal nicotinic acetylcholine receptor ligands in early development at Pfizer
Read More
Anticoagulant, antithrombotic compounds with heterocyclic structure
Read More
Helix describes novel antimicrobial therapeutics particularly for Candida and Pseudomonas infections
Read More
Sigma-Tau prepares new esters useful as cationic lipids for intracellular (gene) delivery
Read More
(Anti)-estrogenic compounds designed at HMR for osteoporosis
Read More
GW-395058 assessed for pharmacokinetics and effects on platelets in monkeys
Read More
Korean farnesyltransferase inhibitor predicted to have favorable PK profile in humans
Read More
IDEC-131: pharmacokinetics and pharmacodynamics in monkeys given repeated infusions
Read More
GTI-2501 associated with complete tumor regression in animal models of kidney and breast cancer
Read More
First toxicity, pharmacokinetic data for JAK3 inhibitors presented at recent scientific meeting
Read More
Therion receives NIH funding for development of novel AIDS vaccines
Read More
Ligand applies for E.U. marketing approval of Targretin as CTCL therapy
Read More
Sindan and Pfizer team up to develop new multitargeted antifolate
Read More
Interneuron licenses U.S. rights to urinary incontinence treatment
Read More
Vertex and Taisho collaborate on caspase inhibitor development
Read More
3-DP investigators study role of MMP in tumor angiogenesis
Read More
Potential lack of drug interactions for the SERMs droloxifene and lasofoxifene
Read More
Vanguard to jump on the M&A bandwagon?
Read More
Neurocrine Biosciences reports positive phase II results with new insomnia agent
Read More
Deracoxib may be suitable for once-daily dosing according to studies in dogs
Read More
New lobucavir prodrug and its quantitative determination along with active compound in plasma
Read More
Lundbeck and Novo Nordisk join forces to discover innovative drug candidates
Read More
FDA approves twice-daily dosing of Viracept
Read More
